Researchers at Indiana University have unveiled a new chemical process that could streamline the development of pharmaceutical compounds. Their study, published in Chem, describes a novel light-driven reaction that efficiently produces tetrahydroisoquinolines, a group of chemicals that play a crucial role in medicinal chemistry.
Tetrahydroisoquinolines serve as the foundation for treatments targeting Parkinson’s disease, cancer, and cardiovascular disorders. These compounds are commonly found in medications such as painkillers and drugs for high blood pressure, as well as in natural sources like plants and marine organisms.
Traditionally, chemists have relied on well-established but limiting methods to synthesize these molecules. Instead, this research harnesses light to trigger a process called photoinduced energy transfer, where light initiates a controlled reaction between sulfonylimines (a type of chemical compound) and alkenes (another type of compound)—leading to the creation of tetrahydroisoquinolines.
This method allows for the development of new structural patterns in the molecules, which were previously difficult or impossible to create using other methods.
The research team found that tiny changes in the location of electrons within the starting materials also had a huge impact on how the reaction played out. By tweaking the shapes of these pieces, the scientists made sure that only the desired product was formed, making the process highly selective. Beyond pharmaceuticals, this research could also impact other industries that rely on fine chemicals.
The researchers say they plan to experiment with different ingredients and settings to improve the process further. They also aim to find out if this method can work on even more types of molecules, expanding its usefulness. In addition, they hope to partner with pharmaceutical companies to test whether the technique can be used to produce medicines.
Information from Indiana University